Nanoviricides (NNVC) Net Cash Flow (2010 - 2026)

Nanoviricides has disclosed Net Cash Flow across 17 years of filings, most recently posting -$2.0 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 38.7% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at $623439.0 (up 187.24% YoY), while the FY2025 annual figure was -$3.3 million, up 2.73% from the prior year.
• Net Cash Flow came in at -$2.0 million for Q1 2026 at Nanoviricides, down from $4.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $4.0 million in Q4 2025 to a low of -$2.0 million in Q1 2024.
• Average Net Cash Flow over 5 years is -$818001.9, with a median of -$1.4 million recorded in 2025.
• The largest YoY upside for Net Cash Flow was 4292.85% in 2025 against a maximum downside of 165.26% in 2025.
• Over 5 years, Net Cash Flow stood at -$1.4 million in 2022, then declined by 21.07% to -$1.7 million in 2023, then surged by 105.32% to $91763.0 in 2024, then surged by 4292.85% to $4.0 million in 2025, then sank by 148.7% to -$2.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$2.0 million in Q1 2026, $4.0 million in Q4 2025, and -$438998.0 in Q3 2025.